Company that makes anthrax vaccine get renewed contract from feds
Emergent Biosolutions has announced that the federal government has extended a contract with the company to continue to produce anthrax vaccines. Emergent , which is based in Rockville MD, makes the vaccine in a Lansing bio-facility. The facility used to belong to the state of Michigan but was privatized by former Gov.
Jul 31, 2020169.2K Shares2.3M Views
Emergent Biosolutions has announced that the federal government has extended a contract with the company to continue to produce anthrax vaccines.
Emergent, which is based in Rockville MD, makes the vaccine in a Lansing bio-facility. The facility used to belong to the state of Michigan but was privatized by former Gov. John Engler.
The contract extension is worth $101 million, reportsthe Lansing State Journal. Under the agreement, the facility will create 3.42 million more doses of the vaccine. The previous contract had Emergent create 14.5 million doses. The extension production will be used to beef up the nation’s stockpile of vaccine.
Emergent’s vaccine, BioThrax, is the only federally approved anthrax vaccine.
Paolo Reyna
Reviewer
Paolo Reyna is a writer and storyteller with a wide range of interests. He graduated from New York University with a Bachelor of Arts in Journalism and Media Studies.
Paolo enjoys writing about celebrity culture, gaming, visual arts, and events. He has a keen eye for trends in popular culture and an enthusiasm for exploring new ideas. Paolo's writing aims to inform and entertain while providing fresh perspectives on the topics that interest him most.
In his free time, he loves to travel, watch films, read books, and socialize with friends.
Latest Articles
Popular Articles